Q. A pathologist is studying the changes associated with infliximab use in a patient with rheumatoid arthritis. In a synovium sample of recently treated patients, immunohistochemistry demonstrates an increased CD 3(+)/CD 4(+)/CD 25(+) cell type. Which of the following cytokines is likely produced from the above-detected cell type?